Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case report

Nefrologia (Engl Ed). 2023 Dec:43 Suppl 2:91-95. doi: 10.1016/j.nefroe.2024.01.018. Epub 2024 Jan 25.

Abstract

Fabry disease or also called Anderson-Fabry disease (FD) is a rare disease caused by pathogenic variants in the GLA gene, located on the X chromosome. This gene is involved in the metabolism of glycosphingolipids and its pathogenic variants cause a deficit or absence of α-galactosidase A causing the deposition of globotriaosylceramide throughout the body. Females have a variable phenotypic expression and a better prognosis than males. This is due to the X chromosome inactivation phenomenon. We present a clinical case of Fabry disease in a female with predominantly renal involvement and demonstrate how the X chromosome inactivation phenomenon is tissue dependent, showing preferential inactivation of the mutated allele at the renal level.

Keywords: Fabry; Globotriaosilceramida; Globotriaosylceramide; Lionización; Lionization; α-Galactosidase A; α-galactosidase A.

Publication types

  • Case Reports

MeSH terms

  • Fabry Disease* / genetics
  • Fabry Disease* / pathology
  • Female
  • Humans
  • Kidney / pathology
  • Male
  • Phenotype
  • X Chromosome Inactivation
  • alpha-Galactosidase / genetics
  • alpha-Galactosidase / metabolism

Substances

  • alpha-Galactosidase